发明名称 BENZODIAZEPINE DERIVATIVES FOR TREATING HEPATITIS C INFECTION
摘要 Use of a benzodiazepine of formula (I), or a pharmaceutically acceptable sal t thereof, in the manufacture of a medicament for use in treating or preventin g a hepatitis C infection, wherein: - R1 represents C1-6 alkyl, aryl or heteroaryl; - R2 represents hydrogen or C1-6 alkyl; - each R3 is the same or different and represents halogen, hydroxy, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, C1-6 haloalkyl, C1-6 haloalkoxy, amino, mono(C1-6 alkyl)amino, di(C1-6 alkyl)amino, nitro, cyano, -CO2R', -CONR'R", -NH-C0-R', -S(O)R', - S(O)2R', -NH-S(O)2R', -S(O)NR'R" or -S(O)2NR'R", wherein each R' and R" is t he same or different and represents hydrogen or C1-6 alkyl; - n is from 0 to 3; - R4 represents hydrogen or C1-6 alkyl; - R5 represents C1-6alkyl, aryl, heteroaryl, carbocyclyl, heterocyclyl, aryl-(C1-6 alkyl)-, heteroaryl-(C1-6 alkyl)-, carbocyclyl-(C1-6 alkyl)-, heterocyclyl-(C1-6 alkyl)-, aryl-(C1-6 hydroxyalkyl)-, heteroaryl-(C1-6hydroxyalkyl)-, carbocyclyl-(C1-6 hydroxyalkyl)-, heterocyclyl-(C1-6hydroxyalkyl)-, aryl-C(O)-C(O)-, heteroary l- C(O)-C(O)-, carbocyclyl-C(O)-C(O)-, heterocyclyl-C(O)-C(O)- or -XR6; - X represents -CO-, -S(O)- or -S(O)2-; and - R6 represents C1-6 alkyl, hydroxy, C1-6 alkoxy, C1-6 alkylthio, aryl, heteroaryl, carbocyclyl, heterocyclyl, ar yl- (C1-6 alkyl)-, heteroaryl-(C1-6 alkyl)-, carbocyclyl-(C1-6 alkyl)-, heterocyclyl-(C1-6 alkyl)-, aryl-(C1-6 alkyl)-O-, heteroaryl-(C1-6 alkyl)-O- , carbocyclyl-(C1-6 alkyl)-O-, heterocyclyl-(C1-6 alkyl)-O- or -NR'R" wherein each R' and R" is the same or different and represents hydrogen, C1-6 alkyl, carbocyclyl, heterocyclyl, aryl, heteroaryl, aryl-(C1-6 alkyl)-, heteroaryl- (C1-6 alkyl)-, carbocyclyl-(C1-6 alkyl)- or heterocyclyl-(C1-6 alkyl)-.</SDO AB>
申请公布号 CA2622592(A1) 申请公布日期 2007.03.29
申请号 CA20052622592 申请日期 2005.09.19
申请人 ARROW THERAPEUTICS LIMITED 发明人 SPENCER, KEITH;COCKERILL, GEORGE;WARNE, JUSTIN;LUMLEY, JAMES;DENNISON, HELENA
分类号 A61K31/5513;A61P31/14;C07D243/24 主分类号 A61K31/5513
代理机构 代理人
主权项
地址